In this study, we performed a comprehensive pan-cancer analysis of PRKCSH, leveraging a range of public databases to investigate its differential expression, prognostic value, clinical correlates, TMB and MSI associations, tumor immune interactions, genetic alterations, DNA methylation patterns, biological functions, drug susceptibility profiles and Cmap analysis. The gene discussed is PRKCSH; the disease is cancer.